Related references
Note: Only part of the references are listed.Heterobivalent Ligand for the Adenosine A2A-Dopamine D2 Receptor Heteromer
Daniel Pulido et al.
JOURNAL OF MEDICINAL CHEMISTRY (2022)
Three-component microwave-assisted synthesis of 3,5-disubstituted pyrazolo[3,4-d]pyrimidin-4-ones
Jia Hui Ng et al.
RSC ADVANCES (2022)
Structure-Based Design of Dual-Acting Compounds Targeting Adenosine A2A Receptor and Histone Deacetylase as Novel Tumor Immunotherapeutic Agents
Wenzhong Yan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Pharmacological characterization of DPTN and other selective A3 adenosine receptor antagonists
Zhan-Guo Gao et al.
PURINERGIC SIGNALLING (2021)
Conjugable A3 adenosine receptor antagonists for the development of functionalized ligands and their use in fluorescent probes
Stephanie Federico et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Pyrazolo[4,3-e][1,2,4]triazol[1,5-c]pyrimidines to develop functionalized ligands to target adenosine receptors: fluorescent ligands as an example
Stephanie Federico et al.
MEDCHEMCOMM (2019)
Preclinical Evaluation and Quantification of 18F-Fluoroethyl and 18F-Fluoropropyl Analogs of SCH442416 as Radioligands for PET Imaging of the Adenosine A2A Receptor in Rat Brain
Shivashankar Khanapur et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
Randomized trial of preladenant, given as monotherapy, in patients with early Parkinson disease
Fabrizio Stocchi et al.
NEUROLOGY (2017)
Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines and Structurally Simplified Analogs. Chemistry and SAR Profile as Adenosine Receptor Antagonists
Sara Redenti et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2016)
CHEM21 selection guide of classical- and less classical-solvents
Denis Prat et al.
GREEN CHEMISTRY (2016)
A New, One-Pot, Multicomponent Synthesis of Bioactive N-Pyrazolylformamidines under Microwave Irradiation
Felicia Phei Lin Lim et al.
SYNTHESIS-STUTTGART (2016)
One-Pot Reaction To Obtain N,N′-Disubstituted Guanidines of Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine Scaffold as Human A3 Adenosine Receptor Antagonists
Pier Giovanni Baraldi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
A one-pot, three-component aminotriazine annulation onto 5-aminopyrazole-4-carbonitriles under microwave irradiation
Felicia Phei Lin Lim et al.
TETRAHEDRON LETTERS (2015)
p53 Functional Inhibitors Behaving Like Pifithrin-β Counteract the Alzheimer Peptide Non-β-amyloid Component Effects in Human SH-SY5Y Cells
Eleonora Da Pozzo et al.
ACS CHEMICAL NEUROSCIENCE (2014)
Synthesis and Isomerization of Some Novel Pyrazolopyrimidine and Pyrazolotriazolopyrimidine Derivatives
Aymn E. Rashad et al.
MOLECULES (2014)
Does the combination of optimal substitutions at the C2-, N5- and N8-positions of the pyrazolo-triazolo-pyrimidine scaffold guarantee selective modulation of the human A3 adenosine receptors?
Siew Lee Cheong et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2011)
Preladenant in patients with Parkinson's disease and motor fluctuations: a phase 2, double-blind, randomised trial
Robert A. Hauser et al.
LANCET NEUROLOGY (2011)
The Significance of 2-Furyl Ring Substitution with a 2-(para-substituted) Aryl Group in a New Series of Pyrazolo-triazolo-pyrimidines as Potent and Highly Selective hA3 Adenosine Receptors Antagonists: New Insights into Structure-Affinity Relationship and Receptor-Antagonist Recognition
Siew Lee Cheong et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Characterization of the Potent and Highly Selective A2A Receptor Antagonists Preladenant and SCH 412348 [7-[2-[4-2,4-Difluorophenyl]-1-piperazinyl]ethyl]-2-(2-furanyl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine] in Rodent Models of Movement Disorders and Depression
Robert A. Hodgson et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
A new synthesis of 2,8-disubstituted pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines
Anton V. Dolzhenko et al.
TETRAHEDRON LETTERS (2009)
Synthesis and antimicrobial activity of some new pyrazole, fused pyrazolo[3,4-d]-pyrimidine and pyrazolo[4,3-e][1,2,4]triazolo[1,5-c] pyrimidine derivatives
Nada M. Abunada et al.
MOLECULES (2008)
A new strategy for the synthesis of pyrazolo[4,3-e][1,2,4]triazolo[4,3-c]pyrimidines and pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines
Ahmad Sami Shawali et al.
TETRAHEDRON (2008)
Pyrazolo [4,3-e][1,2,4]triazolo[1,5-c]pyrimidine template:: Organic and medicinal chemistry approach
PG Baraldi et al.
CURRENT ORGANIC CHEMISTRY (2006)
Alternative routes to the pyrazolo[4,3-e][1,2,4]triazolo-[1,5-c]pyrimidine system
RV Tyurin et al.
RUSSIAN JOURNAL OF ORGANIC CHEMISTRY (2005)
Two approaches to a new heterocyclic system of pyrazolo[4,3-e][1,2,4] triazolo[1,5-c]pyrimidine
Valery V. Mezheritsky et al.
ARKIVOC (2005)
Synthesis of new pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines and related heterocycles
PG Baraldi et al.
TETRAHEDRON (2004)
Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives as adenosine receptor antagonists.: Influence of the N5 substituent on the affinity at the human A3 and A2B adenosine receptor subtypes:: A molecular modeling investigation
G Pastorin et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
Design, synthesis, and biological evaluation of C9- and C2-substituted pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c] pyrimidines as new A2A and A3 adenosine receptors antagonists
PG Baraldi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
Design, radiosynthesis, and biodistribution of a new potent and selective ligand for in vivo imaging of the adenosine A2A receptor system using positron emission tomography
S Todde et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
Synthesis and preliminary biological evaluation of [3H]-MRE 3008-F20:: the first high affinity radioligand antagonist for the human A3 adenosine receptors
PG Baraldi et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2000)
Share Paper
